#celltherapy
LightNews LightNews
qkine.bsky.social
This month we're supporting three events covering a range of topics stem cells, cell therapy and animal-free human specific research.

#conferences #animalfree #humanspecific #stemcells #celltherapy
November 2, 2026 at 9:37 AM
straits2026.bsky.social
Cell and Gene Therapy is transforming modern medicine through innovative treatments and advanced genetic technologies. Discover key industry trends and growth opportunities.

#CellTherapy #GeneTherapy #Healthcare
Cell and Gene Therapy Market
November 3, 2026 at 11:59 AM
crijournal.bsky.social
Allogeneic Dendritic Cells: Transforming the Impact of Cancer Immunotherapy

www.dl.begellhouse.com/journals/2ff...

#DendriticCells #CancerImmunotherapy #CellTherapy
October 30, 2026 at 7:00 PM
celltransplant1992.bsky.social
Machine learning models using longitudinal laboratory data predict survival in allogeneic stem cell recipients
doi.org/10.1177/0963...
#transplant #celltherapy #machinelearning #precisionmedicine
@journals.sagepub.com
October 29, 2026 at 3:30 AM
realfeedapp.com
The agency issued final guidance requiring manufacturers to implement a potency assurance strategy across the entire lifecycle of cell and gene therapy products to ensure batch consistency before patient delivery.

#CellTherapy #GeneTherapy #FDA
FDA issues new rules for cell therapy potency testing
Source: FDA
realfeedapp.com
November 3, 2026 at 7:20 AM
interestingpatents.bsky.social
Editing the RFX gene to reduce its protein expression is proposed to produce cells with altered immune recognition. Janssen Biotech’s patent application covers methods and materials for engineering such hypoimmunogenic cells. #JanssenBiotech #CellTherapy #US20260337579
Fig. 15 from patent document #US20260337579 Fig. 26 from patent document #US20260337579 Fig. 39 from patent document #US20260337579
November 2, 2026 at 6:09 AM
longevitytech.bsky.social
XellSmart’s off-the-shelf XS411 lifted motor scores in nine patients, and its 30-person Phase II trial has finished enrolling.

Link as first comment.

#longevity #geroscience #XellSmart #XS411 #celltherapy
Elderly woman walking with sweater over shoulders and bandage on arm.
October 28, 2026 at 12:25 PM
interestingpatents.bsky.social
Immune cells engineered with multiple antigen receptors plus IL-15 could recognize more than one target for treating immune-related disorders. Patent application from University of Texas System #UTSystem: #US20260325440 #CellTherapy
Fig. 07 from patent document #US20260325440 Fig. 05 from patent document #US20260325440 Fig. 15 from patent document #US20260325440
October 29, 2026 at 7:32 PM
itmat.bsky.social
Armoring #CARTcelltherapy with anti-inflammatory molecules offers new avenues for anti-fibrotic therapies in #ChronicKidneyDisease & other #Fibrosis conditions www.jci.org/articles/vie... @JonEpsteinLab #CellTherapy #CARTCell #TranslationalScience
www.jci.org
October 26, 2026 at 4:36 PM
lifesciencenet.bsky.social
INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar

#News #Biotech #Biotechnology #RareDiseases #CellTherapy

www.lifescience.net/news/7933/in...
INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar
Initial focus on named-patient access in selected European and MENA markets, providing a capital-efficient foundation for broader commercialization.
www.lifescience.net
October 26, 2026 at 2:50 PM
qkine.bsky.social
We're excited to be heading to Boston for @Advanced Therapies USA 2027!

More about the event > zurl.co/fIqFj

We looking forward to talking about our range of animal-free Cell Therapy Grade proteins > zurl.co/taYQo

#animalfree #celltherapy #genetherapy
October 27, 2026 at 8:18 AM
realfeedapp.com
After two participant deaths in a Phase 2a trial for autoimmune diseases, Artiva Biotherapeutics has announced the end of its AlloNK natural killer cell therapy development and major staff cuts. One death was linked to fludarabine chemotherapy, while the cause o…

#CellTherapy #ClinicalTrial #Safety
Two trial participants died
Source: BioPharma Dive
realfeedapp.com
October 27, 2026 at 6:00 PM
purescience.news
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside #Science #Chemistry #MedicinalChemistry #cancercure #japanscience #anticancer #celltherapy #biotechnology
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have developed an...
purescience.news
October 25, 2026 at 7:23 PM
longevitytech.bsky.social
Immorta Bio says its AI-designed SenoMune-0257 prompts T cells to clear senescent cells, and plans first human evaluation before year-end.

Link as first comment.

#longevity #geroscience #ImmortaBio #senescentcells #celltherapy
Abstract image of a chain of colored hexagons near a textured surface.
October 26, 2026 at 11:18 AM
interestingpatents.bsky.social
ENTPD3 can serve as a cell-surface marker to live-sort mature, functional stem cell-derived insulin-producing beta cells, aiming for more uniform populations for diabetes replacement therapy. #UniversityofColorado patent application #US20260325585 #CellTherapy
Fig. 03 from patent document #US20260325585 Fig. 19 from patent document #US20260325585
October 26, 2026 at 1:00 PM
drtimos.bsky.social
🧬 Gene & Cell Therapy | #RareDiseases 🚀
#LucidQuest delivers sharp insights to help biotechs, investors & BD teams stay ahead in fast-moving markets.
📩 info@lqventures.com or http://dlvr.it/TW48TG
#GeneTherapy #CellTherapy #Biotech #DueDiligence #InvestmentInsights
Gene & Cell Therapy and Rare Disease Intelligence - LucidQuest
Strategic insights for gene and cell therapy from R&D through commercialization. Primary KOL research, competitive analysis, and investment diligence in rare diseases.
dlvr.it
October 26, 2026 at 7:05 PM
promegauk.bsky.social
Meet Julia Gilden, Promega one of our Biologics Symposium 2026 speakers, on Thursday, 5 November, 2026 in Oxfordshire

She will present: Luminescent Bioassays for T Cell-Directed Therapeutics, From Engagers to Engineered Cells.

Register: https://ow.ly/cyek50ZZF88

#Biologics #CellTherapy
October 23, 2026 at 10:30 AM
fds.wsocial.eu
#CART-cellTherapy shows lasting improvements in #StiffPersonSyndrome, study finds
#Health
CAR T-cell therapy shows lasting improvements in stiff person syndrome, study finds
New research led by the University of Colorado Anschutz is offering hope to people living with stiff person syndrome (SPS), showing that a CAR T-cell therapy may help change the course of the disease,...
medicalxpress.com
October 21, 2026 at 4:26 PM
theebmt.bsky.social
📣 Apply to become a member of the EBMT Trainee Committee! Contribute with your ideas to build bridges across borders and disciplines in the field of #Haematology, #HCT and #CellTherapy.

🔗Find out more and apply by 6 November: www.ebmt.org/ebmt/news/ap...
October 22, 2026 at 2:35 PM
promegauk.bsky.social
From attendee to speaker: Bethan Archer (Immunocore) first joined us at the 2023 Biologics Symposium as a delegate. This year, she returns to speak at our Biologics Symposium on Thursday, 5 November 2026 in Oxfordshire

Register at: https://ow.ly/52rX50ZZEbJ

#Biologics #CellTherapy
October 22, 2026 at 11:35 AM
fds3rd.bsky.social
#CART-cellTherapy shows lasting improvements in #StiffPersonSyndrome, study finds
#Health
CAR T-cell therapy shows lasting improvements in stiff person syndrome, study finds
New research led by the University of Colorado Anschutz is offering hope to people living with stiff person syndrome (SPS), showing that a CAR T-cell therapy may help change the course of the disease,...
medicalxpress.com
October 21, 2026 at 4:27 PM
realfeedapp.com
The study showed no serious adverse events and substantial motor improvements in nine participants with moderate-to-advanced Parkinson's disease.

#CellTherapy #ParkinsonSDisease #ClinicalTrial
Participants showed motor improvement of more than 30 points
Source: Longevity.Technology
realfeedapp.com
October 20, 2026 at 12:40 PM
realfeedapp.com
Phase 1 data showed tumor shrinkage in all 16 patients with uveal melanoma after receiving experimental cell therapy. Results suggest the therapy could unlock immunotherapy power for other stubborn cancers.

#CellTherapy #UvealMelanoma #Immunotherapy
German biotech presents phase 1 data
Source: STAT News
realfeedapp.com
October 21, 2026 at 10:00 AM
drainteo.bsky.social
An Excellent Singapore 🇸🇬 Stem Cell contingent at ISSCR Kyoto! Celebrating 20th Anniversary for iPSCs.

#stemcells #organoids #celltherapy #imcb #asrl #bti #astar #nus #DukeNUS #lkc #tll #scss
October 20, 2026 at 2:36 PM
cells-mdpi.bsky.social
📢📢 #CallforPapers | Special Issue “Gene and Cell Therapy in Regenerative Medicine—Third Edition”.

📊 Ongoing contributions: 7 papers published
📅 Extended submission deadline: 31 March 2027
👉 www.mdpi.com/journal/cell...

#GeneTherapy #CellTherapy #RegenerativeMedicine #CellsMDPI
October 20, 2026 at 7:18 PM